Acasti Pharma Inc. (ACST) was a big mover last session, as the company saw its shares rise by roughly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now 20% in the past one-month time frame.
This generic drug company has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Acasti Pharma has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the same sector include Akorn, Inc. (AKRX), Mallinckrodt plc (MNK) and Celator Pharmaceuticals, Inc. (CPXX). While Akorn and Mallinckrodt hold a Zacks Rank #1 (Strong Buy), Celator Pharmaceuticals carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ACASTI PHARMA CL A (ACST): Free Stock Analysis Report
AKORN INC (AKRX): Free Stock Analysis Report
MALLINCKRODT PUBLIC LTD CO (MNK): Free Stock Analysis Report
CELATOR PHARMACEUTICALS INC (CPXX): Free Stock Analysis Report
Zacks Investment Research